Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 29/11/2020
SIETES contiene 93175 citas

 
 
 1 a 20 de 20 
Presentar resultados
Seleccionar todas
1. Cita con resumen
Yank V, Tuohy CV, Logan AC, Bravata DM, Staudenmayer K, Eisenhut R, Sundaram V, McMahon D, Olkin I, McDonald KM, Owens DK, Stafford RS. Systematic review: benefits and harm of in-hospital use of recombinant factor VIIa for off-label indications. Ann Intern Med 2011;154:529-40. [Ref.ID 91274]
2. Cita con resumen
Banerjee D, Stafford RS. Lack of improvement in outpatient management of congestive heart failure in the United States. Arch Intern Med 2010;170:1399-400. [Ref.ID 89088]
3.
Stafford RS, Bartholomew LK, Cushman WC, Cutler JA, Davis BR, Dawson G, Einhorn PT, Furberg CD, Piller LB, Pressel SL, Whelton PK, for the ALLHAT Collaborative Research Group. Impact of the ALLHAT/JNC7 dissemination project of thiazide-type diuretic use. Arch Intern Med 2010;170:851-8. [Ref.ID 88578]
4.
Stafford RS, Wagner TH, Lavori PW. New, but not improved? Incorporating comparative-effectiveness information into FDA labeling. N Engl J Med 2009;361:1230-3. [Ref.ID 86817]
5. Cita con resumen
Alexander GC, Sehgal NL, Moloney RM, Stafford RS. National trends in treatment of type 2 diabetes mellitus, 1994-2007. Arch Intern Med 2008;168:2088-94. [Ref.ID 84326]
6. Cita con resumen
Stafford RS. Regulating off-label drug use - rethinking the role of the FDA. N Engl J Med 2008;358:1427-9. [Ref.ID 82522]
7.
Gardner CD, Kiazand A, Alhassan S, Kim S, Stafford RS, Balise RR, Kraemer HC, King AC. Comparison of the Atkins, Ornish, and LEARN diets for change in weight and related risk factors among overweight premenopausal women. The A to Z Weight Loss Study: a randomized trial. JAMA 2007;297:969-77. [Ref.ID 79548]
8.
Radley DC, Finkelstein SN, Stafford RS. Off-label prescribing among office-based physicians. Arch Intern Med 2006;166:1021-6. [Ref.ID 76949]
9.Enlace a cita original
Almasi EA, Stafford RS, Kravitz RL, Mansfield PR. What are the public health effects of direct-to-consumer drug advertising?. PLOS Medicine 2006;3:284. [Ref.ID 76593]
11. Cita con resumen
Majumdar SR, Almasi EA, Stafford RS. Promotion and prescribing of hormone therapy report of harm by the women's health initiative. JAMA 2004;292:1983-8. [Ref.ID 71726]
12.Tiene citas relacionadas Cita con resumen
Cushman M, Kuller LH, Prentice R, Rodabough R J, Psaty B M, Stafford RS, Sidney S, Rosendaal F R, for the Women's Health Initiative Investigators. Estrogen plus progestin and risk of venous thrombosis. JAMA 2004;292:1573-80. [Ref.ID 71586]
13.
Fang MC, Stafford RS, Ruskin J N, Singer DE. National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation. Arch Intern Med 2004;164:55-60. [Ref.ID 68688]
14.Tiene citas relacionadas Cita con resumen
Stafford RS, Furberg CD, Finkelstein SN, Cockburn IM, Alehegn T, Ma J. Impact of clinical trial results on national trends in alfa-blocker prescribing, 1996-2002. JAMA 2004;291:54-62. [Ref.ID 68646]
15.Tiene citas relacionadas Cita con resumen
Hersh AL, Stefanick ML, Stafford RS. National use of postmenopausal hormone therapy. Annual trends and response to recent evidence. JAMA 2004;291:47-53. [Ref.ID 68645]
16.
Stafford RS, Radley D C. National trends in antiobesity medication use. Arch Intern Med 2003;163:1046-50. [Ref.ID 66276]
17. Cita con resumen
Huang ES, Stafford RS. National patterns in the treatment of urinary tract infections in women by ambulatory care physicians. Arch Intern Med 2002;162:41-7. [Ref.ID 60286]
18.Tiene citas relacionadas
Linder JA, Stafford RS. Antibiotic treatment of adults with sore throat. In reply. JAMA 2001;286:2943. [Ref.ID 59880]
20. Cita con resumen
Stafford RS, Singer DE. Recent national patterns of warfarin use in atrial fibrillation. Circulation 1998;97:1231-3. [Ref.ID 38327]
Seleccionar todas
 
 1 a 20 de 20